How many email patterns does AVM Biotechnology use?

AVM Biotechnology uses 2 known email patterns.

What domain does AVM Biotechnology use for work emails?

AVM Biotechnology uses avmbiotech.com for work email addresses.

Most Common Email Formats at AVM Biotechnology

AVM Biotechnology's most common email format is FLast@avmbiotech.com (ex. JDoe@avmbiotech.com), used for 98% of avmbiotech.com addresses. AVM Biotechnology uses 2 email patterns.

@avmbiotech.com

2 patterns

Format	Example	Share of avmbiotech.com
FLast@avmbiotech.comMost common	JDoe@avmbiotech.com	98%
First.Last@avmbiotech.com	John.Doe@avmbiotech.com	2%

Frequently Asked Questions

What does AVM Biotechnology do?

AVM Biotechnology was founded in 2008 and operates in the Biotechnology Research industry, alongside similar companies like Johnson & Johnson, Vertex Pharmaceuticals and Moderna. You can visit avmbiotech.com or contact AVM Biotechnology's headquarters by phone at

+1-206-906-****

. Explore AVM Biotechnology's company overview page for more information.

What is AVM Biotechnology's email address format?

AVM Biotechnology's email format typically follows the pattern of FLast@avmbiotech.com; this email format is used 98% of the time. Other contacts within LeadIQ's database had email formats such as First.Last@avmbiotech.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does AVM Biotechnology have currently?

AVM Biotechnology has approximately 14 employees as of November 2026. Key team members to contact include Chief Medical Officer - Compassionate Use Program: E. L., Operations Manager: M. L. and Cinematographer: K. S. For more team information and contact data, explore AVM Biotechnology's employee directory with LeadIQ.

AVM Biotechnology Email Format

Biotechnology ResearchWashington, United States11-50 Employees

AVM Biotechnology is a Seattle-based biotechnology research company focused on developing AVM0703, a proprietary formulation of dexamethasone designed for supra-pharmacologic dosing to mobilize the body's immune system. The program is described as triggering the production of endogenous gamma delta TCR+ invariant TCR+ bispecific T lymphocytes and Natural Killer T cells, with potential applications in cancer, autoimmune diseases, and infectious diseases, while emphasizing safety and reduced treatment-related suffering.

Operating in the clinical-stage biotech space, AVM targets cancer, autoimmune disorders, and infectious diseases through immunomodulatory approaches. It was founded by Dr. Theresa Deisher and supports its research with a Scientific Advisory Board comprising leaders in cancer and immunology. In early 2024, AVM Biotechnology announced a collaboration with Xtacy Therapeutics, indicating active external partnerships alongside its development efforts.

Most Common Email Formats at AVM Biotechnology

@avmbiotech.com

Need a specific person's email?

Frequently Asked Questions

What does AVM Biotechnology do?

What is AVM Biotechnology's email address format?

How many employees does AVM Biotechnology have currently?

AVM Biotechnology Email Format

Ready to create more pipeline?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Most Common Email Formats at AVM Biotechnology

@avmbiotech.com

Need a specific person's email?

Frequently Asked Questions

What does AVM Biotechnology do?

What is AVM Biotechnology's email address format?

How many employees does AVM Biotechnology have currently?

AVM Biotechnology Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.